Mark Markowski

Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Castration 58%
3. 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 45%
4. Androgens 45%
5. MDV 3100 38%
6. Prostate-Specific Antigen 29%
7. abiraterone 20%
8. Prostatectomy 17%
9. Androgen Receptors 16%
10. Neoplasm Metastasis 13%
11. Therapeutics 13%
12. Renal Cell Carcinoma 12%
13. Individual Biological Variation 10%
14. Survival 10%
15. Positron-Emission Tomography 10%
16. Prostate 9%
17. Membranes 9%
18. Radium-223 9%
19. Neoplasms 9%
20. Testosterone 8%
21. Mutation 8%
22. Progression-Free Survival 7%
23. Salvage Therapy 6%
24. Radiotherapy 6%
25. molibresib 5%
26. Hormones 5%
27. methionine aminopeptidase 2 5%
28. Drug Therapy 5%
29. Urogenital Neoplasms 5%